تحلیل اختیاری محصول
با اجازه شما، از تحلیلهای محدود و حریمخصوصیمحور استفاده میکنیم تا مسیرهای پژوهشی مؤثر را بشناسیم. از ردیاب تبلیغاتی یا بازپخش نشست استفاده نمیکنیم. این انتخاب را میتوانید در تنظیمات تغییر دهید. بخوانید سیاست حفظ حریم خصوصی.
McCormick & Company Incorporated's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $13.1B |
|---|
| Revenue (ttm) | 7.7B |
|---|
| Net income (ttm) | 1.5B |
|---|
| EPS (ttm) | $5.53 |
|---|
| Shares out | 269.1M |
|---|
| P/E (trailing) | 8.3x |
|---|
| P/E (forward) | 14.2x |
|---|
| Dividend | $1.92 (4.19%) |
|---|
| Volume | 3,490,079 |
|---|
| Beta | 0.64 |
|---|
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | Trend |
| Revenue | $6.32B | $6.35B | $6.66B | $6.72B | $6.84B | +2.0% |
| Gross profit | $2.49B | $2.27B | $2.50B | $2.59B | $2.59B | +1.0% |
| Operating income | $1.02B | $863.6M | $963.0M | $1.06B | $1.07B | +1.3% |
| Net income | $755.3M | $682.0M | $680.6M | $788.5M | $789.4M | +1.1% |
| EPS (diluted) | $2.80 | $2.52 | $2.52 | $2.92 | $2.93 | +1.1% |
| EBITDA | $1.22B | $1.16B | $963.0M | $1.32B | $1.34B | +2.4% |
| R&D | $87.3M | $87.5M | $94.9M | $102.9M | $106.1M | +5.0% |
| SG&A | $1.40B | $1.36B | $1.48B | $1.52B | $1.50B | +1.7% |
Recent company headlines from major financial publishers.
The base path expects steady compound growth driven by essential consumer seasoning demand and ongoing B2B flavor development partnerships. Disconfirmation would appear by mid-FY2027 if retail promotional pressure erodes shelf leadership or key retail partners demand pricing concessions.
The bull path reflects accelerated geographic expansion across EMEA and Asia Pacific, accompanied by premium brand mix shift and faster food service volume recovery. Disconfirmation would emerge if international sales decelerate or custom flavor contracts fail to expand product lines by late FY2027.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 4.9% | $69.5 | $76.0 | $84.9 | $98.0 | $120 |
| 5.9% | $58.5 | $62.1 | $66.8 | $72.9 | $81.4 |
| 6.9% | $51.2 | $53.5 | $57.6 | $59.8 | $64.2 |
| 7.9% | $45.9 | $47.5 | $49.3 | $51.5 | $54.2 |
| 8.9% | $41.9 | $43.0 | $44.3 | $45.8 | $47.6 |
Upcoming earnings date and setup when available.
رتبهای که نسخهٔ پژوهشی منتشرشدهٔ هر ماه داشت. رتبه قیمت در تاریخ تحلیل را با ارزش منصفانه مقایسه میکند و سابقهای از درستی یا نادرستی ارزیابی نیست.
| سال | دی | بهمن | اسفند | فروردین | اردیبهشت | خرداد | تیر | مرداد | شهریور | مهر | آبان | آذر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |